CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Randomized Study of Isolated Limb Perfusion Using Melphalan With or Without Tumor Necrosis Factor in Patients With Unresectable High Grade Soft Tissue Sarcomas of the Extremity

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00019968
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:30.087263+00:00
Published At: 2023-10-31T00:00:00+00:00
Record Updated At: 2023-10-31
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Stage IVB Adult Soft Tissue Sarcoma", "Stage IIB Adult Soft Tissue Sarcoma", "Stage IIC Adult Soft Tissue Sarcoma", "Recurrent Adult Soft Tissue Sarcoma", "Stage IVA Adult Soft Tissue Sarcoma", "Stage III Adult Soft Tissue Sarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-10-31"
protocolSection.identificationModule.nctId: "NCT00019968"
protocolSection.identificationModule.officialTitle: "Phase II Randomized Study of Isolated Limb Perfusion Using Melphalan With or Without Tumor Necrosis Factor in Patients With Unresectable High Grade Soft Tissue Sarcomas of the Extremity"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.